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1. INTRODUCTION {#mgg31100-sec-0005}
===============

Arthrogryposis multiplex congenita (AMC) is a rare neuromuscular syndrome with an incidence of one in 3000--5000 live births (Lowry, Sibbald, Bedard, & Hall, [2010](#mgg31100-bib-0014){ref-type="ref"}). AMC is characterized by contracted muscles and nonprogressive congenital contractures of at least two different joints with thick periarticular capsules (Bamshad, Van Heest, & Pleasure, [2009](#mgg31100-bib-0002){ref-type="ref"}; Hall, [2013](#mgg31100-bib-0006){ref-type="ref"}). However, the mechanism underlying its pathogenesis is still unclear (Hall, [2012](#mgg31100-bib-0005){ref-type="ref"}, [2014](#mgg31100-bib-0007){ref-type="ref"}). As a heterogeneous disorder, AMC could be a single‐gene disorder or sporadic without known genetic defect. Currently, over 300 genes are associated with AMC, among which 50 are X‐linked (Bayram et al., [2016](#mgg31100-bib-0003){ref-type="ref"}; Hall, [2014](#mgg31100-bib-0007){ref-type="ref"}; Hall & Kiefer, [2016](#mgg31100-bib-0008){ref-type="ref"}; Hunter et al., [2015](#mgg31100-bib-0011){ref-type="ref"}; Michalk et al., [2008](#mgg31100-bib-0016){ref-type="ref"}). In 1985, Wieacker et al reported 6 males in a family suffering from a syndrome with multiple congenital contractures, slowly progressive distal muscular atrophy, ocular movement disorder, and mild intellectual disability (ID) (Wieacker et al., [1985](#mgg31100-bib-0021){ref-type="ref"}). The syndrome was then named after him as Wieacker‐Wolff syndrome (WWS). WWS is a rare intellectual and developmental disability (IDD) disease. As a severe X‐linked neurodevelopmental disorder with arthrogryposis, mutations in the *ZC4H2* (Zinc Finger C4H2‐Type Containing) gene were identified to associate with WWS in 5 families and 3 sporadic cases with AMC and ID (Hirata et al., [2013](#mgg31100-bib-0010){ref-type="ref"}). The male patients have more severe symptoms than female as the disease had been originally identified to be X‐linked recessive inheritance (Hirata et al., [2013](#mgg31100-bib-0010){ref-type="ref"}; Wieacker et al., [1985](#mgg31100-bib-0021){ref-type="ref"}). However, female patients show various symptoms especially in deletion and nonsense mutation cases, and some of them are considered to be associated with nonrandom X‐chromosome inactivation (XCI) (Hirata et al., [2013](#mgg31100-bib-0010){ref-type="ref"}). So far, 7 missense mutations, 1 nonsense mutation, 1 frameshift mutation, 1 chromosomal breakpoint in Xq11.2, and 4 deletions in *ZC4H2* gene have been reported (Figure [1](#mgg31100-fig-0001){ref-type="fig"}) (Godfrey, Dowlatshahi, Martin, & Rothkopf, [2018](#mgg31100-bib-0004){ref-type="ref"}; Hennekam, Barth, Van Lookeren Campagne, De Visser, & Dingemans, [1991](#mgg31100-bib-0009){ref-type="ref"}; Hirata et al., [2013](#mgg31100-bib-0010){ref-type="ref"}; Kondo et al., [2018](#mgg31100-bib-0013){ref-type="ref"}; May et al., [2015](#mgg31100-bib-0015){ref-type="ref"}; Okubo et al., [2018](#mgg31100-bib-0018){ref-type="ref"}; Zanzottera et al., [2017](#mgg31100-bib-0023){ref-type="ref"}). The clinical presentation and genetic changes in female patients have been summarized in Table [1](#mgg31100-tbl-0001){ref-type="table"}.

![Schematic diagram of ZC4H2 with mutations. The structure of the human *ZC4H2* gene is schematically represented. All known mutations are shown at the top of the picture, while the position where the chromosome is deleted or inverted is shown at the bottom of the figure. Nucleotide numbering designates the A of the translation start codon ATG as +1. The numbered boxes represent exon. The "/"sign stands for deletion, while "×"signs shows the break point area."\*" (c.199C\>T) indicates the patient in the present study](MGG3-8-e1100-g001){#mgg31100-fig-0001}

###### 

Comparison of physical presentation of female cases with ZC4H2 mutations

<table><thead><tr class="header"><th></th><th>Family 1</th><th>Family 2</th><th>Family 3</th><th>Family 4</th><th>Family 5</th><th>Family 6</th><th>Family 7</th><th>Family 8</th><th>Family 9</th><th>Simplex case 1</th><th>Simplex case 2</th><th>Simplex case 3</th><th>Simplex case 4</th><th>Simplex 5</th><th>Present case</th></tr></thead><tbody><tr class="odd"><td>mutation</td><td>c.593G&gt;A (p.R198Q)</td><td>c.601C&gt;T (p.P201S)</td><td>c.637C&gt;T (p.R213W)</td><td>c.637C&gt;T (p.R213W)</td><td>c.197T&gt;A (p.L66H)</td><td>c.637C&gt;T (p.R213W)</td><td>in‐frame insertion: c.225+5G&gt;A (p.V75in15aa)</td><td>c.53G&gt;A (p.R18K)</td><td>c.627G&gt;C (p.K209N)</td><td>Gene deletion: 63,666, 909‐64,493, 512</td><td>Gene deletion: 64,049, 596‐64,370, 757</td><td>Gene deletion: 63,898,170‐64,327,237</td><td><p>Gene deletion: 63,932,</p><p>104‐64,327,</p><p>267</p></td><td>c.148C&gt;T (p.Q50X)</td><td>c.199C&gt;T (p.R67X)</td></tr><tr class="even"><td>First author</td><td>Hirata et al. (<a href="#mgg31100-bib-0010" data-ref-type="ref">2013</a>)</td><td>Hennekam et al. (<a href="#mgg31100-bib-0009" data-ref-type="ref">1991</a>)</td><td>Hirata et al. (<a href="#mgg31100-bib-0010" data-ref-type="ref">2013</a>)</td><td>Hirata et al. (<a href="#mgg31100-bib-0010" data-ref-type="ref">2013</a>)</td><td>Miles&amp; Carpenter (<a href="#mgg31100-bib-0017" data-ref-type="ref">1991</a>)</td><td>May et al. (<a href="#mgg31100-bib-0015" data-ref-type="ref">2015</a>)</td><td>May et al. (<a href="#mgg31100-bib-0015" data-ref-type="ref">2015</a>)</td><td>May et al. (<a href="#mgg31100-bib-0015" data-ref-type="ref">2015</a>)</td><td>Kondo et al. (<a href="#mgg31100-bib-0013" data-ref-type="ref">2018</a>)</td><td>Hirata et al. (<a href="#mgg31100-bib-0010" data-ref-type="ref">2013</a>)</td><td>Hirata et al. (<a href="#mgg31100-bib-0010" data-ref-type="ref">2013</a>)</td><td>Zanzottera et al. (<a href="#mgg31100-bib-0023" data-ref-type="ref">2017</a>)</td><td>Okubo et al. (<a href="#mgg31100-bib-0018" data-ref-type="ref">2018</a>)</td><td>Godfrey et al. (<a href="#mgg31100-bib-0004" data-ref-type="ref">2018</a>)</td><td></td></tr><tr class="odd"><td>Affected individuals</td><td>6</td><td>12</td><td>3</td><td>4</td><td>10</td><td>7</td><td>6</td><td>8</td><td>3</td><td>1</td><td>1</td><td>1</td><td>1</td><td>1</td><td>1</td></tr><tr class="even"><td>Affected females</td><td>1</td><td>7</td><td>1</td><td>2</td><td>6</td><td>4</td><td>3</td><td>4</td><td>1</td><td>1</td><td>1</td><td>1</td><td>1</td><td>1</td><td>1</td></tr><tr class="odd"><td>XCI pattern</td><td>Skewed</td><td>Skewed</td><td>Normal</td><td>NA</td><td>Skewed</td><td>95:5/97:3</td><td>57:48</td><td>91:9</td><td>NA</td><td>Skewed</td><td>Skewed</td><td>Normal</td><td>NA</td><td>24:76</td><td>22:78</td></tr><tr class="even"><td>Short neck</td><td>–</td><td>1</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>1</td><td>–</td><td>1</td><td>–</td><td>1</td></tr><tr class="odd"><td>High arched palate</td><td>–</td><td>1</td><td>–</td><td>–</td><td>2</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>1</td><td>–</td><td>–</td><td>–</td><td>1</td></tr><tr class="even"><td>Radial deviation of fingers</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>1</td><td>1</td><td>–</td><td>1</td><td>1</td></tr><tr class="odd"><td>Ulnar deviation of fingers</td><td>–</td><td>1</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>1</td><td>–</td><td>1</td><td></td></tr><tr class="even"><td>Camptodactyly</td><td>–</td><td>5</td><td>–</td><td>–</td><td>3</td><td>–</td><td>–</td><td>–</td><td>1</td><td>1</td><td>1</td><td>–</td><td>–</td><td>–</td><td>1</td></tr><tr class="odd"><td>Proximally placed thumbs</td><td>–</td><td>–</td><td>–</td><td>–</td><td>4</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>1</td><td>–</td><td>–</td><td>–</td><td>1</td></tr><tr class="even"><td>Short toes</td><td>–</td><td>1</td><td>–</td><td>–</td><td>1</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td></td></tr><tr class="odd"><td>Hip dislocation or contractures</td><td>–</td><td>1</td><td>–</td><td>–</td><td>1</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>1</td><td>1</td><td>1</td><td>1</td><td>1</td></tr><tr class="even"><td>Kyphosis, lordosis, or scoliosis</td><td>–</td><td>3</td><td>–</td><td>–</td><td>2</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>1</td><td>1</td><td>1</td><td>–</td><td>1</td></tr><tr class="odd"><td>Talipes equinus</td><td>1</td><td>3</td><td>–</td><td>–</td><td>1</td><td>–</td><td>–</td><td>–</td><td>–</td><td>1</td><td>1</td><td>1</td><td>1</td><td>–</td><td>1</td></tr><tr class="even"><td>Intellectual disability</td><td>–</td><td>3</td><td>1</td><td>2</td><td>2</td><td>2</td><td>1</td><td>1</td><td>–</td><td>3</td><td>1</td><td>1</td><td>1</td><td>1</td><td>1</td></tr><tr class="odd"><td>Seizures</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>1</td><td>1</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td></tr><tr class="even"><td>MRI</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>Slight ventricularenlargeme‐nt</td><td>Progressive diffuse cerebral atrophy</td><td>–</td><td>Normal</td></tr><tr class="odd"><td>NCV</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>Normal</td><td>Normal</td><td>–</td><td>–</td></tr><tr class="even"><td>BAEP</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>Only waves I and II as normal latencies at 102dB</td><td>–</td><td>Wave I, III and V increased latency responses of the right and left ears at 80dB and 90dB respectivel‐y</td></tr><tr class="odd"><td>EEG</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>Occasional focal epileptic abnormalities in both hemispheres</td><td>No epileptic discharges, but disorganiz‐ed theta range activities</td><td>–</td><td>Normal</td></tr></tbody></table>
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The human *ZC4H2* gene is located on the long arm of the X chromosome (Xq11.2) with 5 exons and encodes a member of the zinc finger domain‐containing protein family. Its C‐terminus has a typical zinc finger domain with four cysteine residues and two histidine residues. The expression of ZC4H2 is highest during embryonic development as well as immature neurons, and declined postnatally as well as in mature neurons, indicating its important role in the development of the nervous system (Hirata et al., [2013](#mgg31100-bib-0010){ref-type="ref"}). *ZC4H2* has been considered as a potential candidate gene for X‐linked cognitive disability. Homozygous ZC4H2 mutant results in abnormal swimming capacity, pectoral fin flexion, and eye position in zebrafish (May et al., [2015](#mgg31100-bib-0015){ref-type="ref"}). These findings are consistent with contractures and exotropia observed in patients with ZC4H2 mutations.

In this study, we identified a novel mutation in *ZC4H2* gene in a female patient suffering from Wieacker‐Wolff syndrome. We investigated the XCI pattern of this patient and subcellular location of the truncated ZC4H2 protein. Our study provided novel insights into ZC4H2\'s role in the pathogenesis of Wieacker‐Wolff syndrome.

2. MATERIALS AND METHODS {#mgg31100-sec-0006}
========================

2.1. Ethical approval {#mgg31100-sec-0007}
---------------------

All samples were collected after the couple had given their written informed consent, and the study was approved by the research ethical committee of the Children\'s Hospital of Chongqing Medical University.

2.2. Whole‐exome sequencing {#mgg31100-sec-0008}
---------------------------

Coding exons were captured using the GenCap Liquid Phase Capture Kit (MyGenostics Inc) and sequenced on the Illumina NextSeq 500. Bcl2fastq conversion software was used for image analysis and base calling. Exome data processing, variant calling, and variant annotation were performed using BWA + GATK + ANNOVAR. Sequenced data were mapped to the genome assembly UCSC hg19 human reference genome. Single‐nucleotide variations and small indels were identified using the HaplotypeCaller in GATK software. Variant sequences were filtered using VariantFiltration in GATK software. Filter‐passed variants were annotated with ANNOVAR software.

2.3. Plasmids {#mgg31100-sec-0009}
-------------

ZC4H2 (NM_018684) Human Tagged ORF Clone with C‐terminal Flag tag (RC202589) was purchased from Origene. The R67X mutation (c.199C\>T, p. R67X) was generated by using the QuikChange Lightning Site‐Directed Mutagenesis Kit (Stratagene) with following primers: forward, CATGTGGAGGAACTCTGACTGATCCACGCTG; reverse, CAGCGTGGATCAGTCAGAGTTCCTCCACATG. To tag EGFP to the N‐terminus of the ZC4H2 protein, ZC4H2 cDNA was subcloned into pEGFP‐C2 vector at XhoI/BamHI sites. The primers used for cloning EGFP‐ZC4H2 cDNA were as follows: forward 5ʹ‐CCGCTCGAGCATGGCAGATGAGCAAGAAA‐3ʹ; reverse 5ʹ‐CGCGGATCCTTATTCATCCTGCTTCCGT‐3ʹ. The clones were determined by restriction enzyme digestion followed by agarose gel electrophoresis, and the sequences were further confirmed by Sanger sequencing.

2.4. Cell culture and immunoblot analysis {#mgg31100-sec-0010}
-----------------------------------------

HEK293T cells were grown in Dulbecco\'s Modified Eagle Medium supplemented with 10% fetal bovine serum, penicillin (100 units/ml), and streptomycin (100 µg/ml) at 37°C with 5% CO2 until 95% confluence was attained.

A total of 5 × 10^5^ HEK293T cells were grown in 6‐well plates, and 4 μg of plasmid DNA was transfected using Lipofectamine2000 (Invitrogen) according to the manufacturer\'s recommendations. For Western blot analysis (Zhang et al., [2018](#mgg31100-bib-0024){ref-type="ref"}), twenty‐four hours later, the cells were lysed in RIPA buffer supplemented with the protease inhibitor cocktail (Roche Diagnostics), sonicated and centrifuged for 10 min at 12,000 rpm at 4°C. The samples were boiled after being diluted in 5 × SDS sample buffer, and equal quantities of total protein per lane were separated on 15% Tris‐glycine‐SDS‐PAGE followed by transfer to polyvinylidene fluoride (PVDF‐FL) membranes. Immunoblots were incubated with the following primary and secondary antibodies: rabbit polyclonal anti‐ZC4H2 (1:1,000; Thermo Fisher), rabbit polyclonal anti‐GFP (1:1,000; Beyotime).

2.5. Confocal fluorescent microscopic analysis {#mgg31100-sec-0011}
----------------------------------------------

HEK293T cells were plated on 20 mm diameter glass coverslips in 12‐well plates and transfected using 0.2% Lipofectamine2000 (Invitrogen) with 2 μg wild type or mutant ZC4H2. After 24 hr of transfection, the cells were fixed with 4% paraformaldehyde for 20 min and permeabilized in 0.5% Triton X‐100 for 30 min and then stained with Actin‐Stain^TM^ 555 phalloidin (CST) and DAPI.

2.6. X‐chromosome inactivation (XCI) assay {#mgg31100-sec-0012}
------------------------------------------

Genomic DNA Purification Kit (Promega) was used to extract human genomic DNA from peripheral blood leukocytes. XCI analysis was performed using well‐characterized CpG methylation sites and polymorphic CAG repeats in exon 1 of androgen receptor (AR), according to the standard protocol (Allen, Zoghbi, Moseley, Rosenblatt, & Belmont, [1992](#mgg31100-bib-0001){ref-type="ref"}). The ratio of shorter allele to longer allele was determined by methylation‐sensitive restriction enzyme HpaII digestion followed by PCR amplification.

3. RESULTS {#mgg31100-sec-0013}
==========

3.1. Case report {#mgg31100-sec-0014}
----------------

This patient is the first child of healthy nonconsanguineous parents of Chinese origin. She was born at term by scheduled cesarean section delivery due to breech presentation. Her birth weight (BW) was 3,150 g (25th‐50th percentile), birth length (BL) 47.5 cm (10th‐25th percentile), and occipito‐frontal circumference (OFC) was 34.3 cm (50th percentile). The total Apgar (Appearance, Pulse, Grimace, Activity, and Respiration) score was 8, 10 and 10 at 1, 5, and 10 min after birth, respectively. Physical examination at birth demonstrated AMC and congenital developmental malformation (Figure [2](#mgg31100-fig-0002){ref-type="fig"}a). Cranial MRI and chest X‐ray were normal, but echocardiography showed foramen ovale and the newborn hearing screening test was unsuccessful. Karyotype analysis and electroencephalogram were normal. At 45 days, her weight, length and OFC grew to 4,150 g, 51.5 cm, and 34.3 cm, respectively. At 2 months, a hip joint MRI indicated right developmental dysplasia of the hip (Figure [2](#mgg31100-fig-0002){ref-type="fig"}b). At 3 months, brainstem auditory evoked potential (BAEP) showed the increased wave I, III, and V latency responses of the right and left ears at 80 and 90 dB, respectively. General movement assessment revealed mildly abnormal general movements. Electroencephalogram was normal. X‐rays of the spine, hand and foot showed waist scoliosis, camptodactyly of the fingers, extorsion of the hands, and vertical talus. Since then, she has received rehabilitation training at a local healthcare center. At 3 months of age, she was taken to our hospital because of global developmental delay. During physical examination, she could not control her head and presented with truncal hypotonia as well as AMC. She also presented with flat nose; short neck; high, narrow palate, and short toes (Figure [2](#mgg31100-fig-0002){ref-type="fig"}a). The Gesell Infant Development Scale (GESELL) (Chinese edition) test showed gross motor skills (GM) 11, fine motor skills (FM) 28, adaptability (AD) 39, language (L) 50, and personal social activity (PS) 50. Her fine and gross motor abilities were 1 + month and 0--1 month. Brain MRI and chest X‐ray were normal. At 22 months of age, she could sit for a while and hold a bottle and drink milk by herself. When her parents put a biscuit in her hands, she was able to put it in her mouth slowly. She could not stand, and imaging examination showed osteonecrosis of the femoral head. The patient presents a typical WWS case.

![Clinical features of the female patient. (a) Images of the patient at 3 days, 7 months, and 22 months after birth showed overlapping and camptodactyly of fingers, right club foot, short neck, narrow shoulder, and short toes. (b) At 10 days, brain MRI is normal, pelvic MRI at 2 months showed right hip dislocation, and X‐ray of limb at 3 months shows fixed contractures of fingers and vertical talus](MGG3-8-e1100-g002){#mgg31100-fig-0002}

3.2. Next‐generation sequencing identifies nonsense mutations in ZC4H2 {#mgg31100-sec-0015}
----------------------------------------------------------------------

To identify the pathogenic mutations in this patient, whole‐exome sequencing (WES) followed by Sanger sequencing was performed on the blood DNA samples of the proband and her parents (Figure [3](#mgg31100-fig-0003){ref-type="fig"}a). We identified a heterozygous nonsense mutation in the *ZC4H2* gene (c.199C\>T, p. R67X) in this patient but not in her father and mother, indicating that the patient has a de novo mutation (Figure [3](#mgg31100-fig-0003){ref-type="fig"}b). This mutation creates a new stop codon at amino acid residue 67 of ZC4H2 protein, resulting in a truncated ZC4H2 protein with 66 amino acids and lacking the last 158 amino acids at the C‐terminus (Figure [3](#mgg31100-fig-0003){ref-type="fig"}c). The mammalian expression plasmids carrying wild‐type ZC4H2 cDNA or the mutant ZC4H2‐R67X were constructed and the proteins were fused with EGFP tag at N‐terminus or with Flag tag at C‐terminus. The plasmids were transfected into HEK293T cells, and Western blot analysis was performed to examine the expression of the fusion proteins with anti‐EGFP antibody. The wild‐type plasmid with N‐terminal EGFP tag expressed full‐length EGFP‐ZC4H2 proteins, whereas the mutant plasmid expressed a shorter version of EGFP‐truncated ZC4H2 proteins (Figure [3](#mgg31100-fig-0003){ref-type="fig"}d). The results were further confirmed by expression of C‐terminal Flag‐fused ZC4H2 proteins. The wild‐type plasmid with C‐terminal Flag tag expressed full‐length Flag‐ZC4H2 proteins; in contrast, the mutant plasmid carries a stop codon between N‐terminus of ZC4H2 and C‐terminal Flag, resulting in failed identification of a Flag‐fused protein (Figure [3](#mgg31100-fig-0003){ref-type="fig"}e). These results clearly demonstrated that we have discovered a novel WWS‐associated nonsense mutation in ZC4H2 gene that results in a truncated protein.

![Identification of a de novo nonsense mutation R67X in *ZC4H2* gene. (a) Pedigree of the patient with ZC4H2 p.R67X mutation. (b) Sanger sequencing of *ZC4H2* gene in genomic DNA from the proband and her father and mother. The c.199C\>T (p. R67X) was found in the patient but not in her parents, suggesting that the mutation was de novo. (c) Schematic diagram of ZC4H2 gene structure with mRNA and protein products. Wild type and mutant ZC4H2 coding sequences surrounding the mutation were shown. (d) HEK293T cells were transfected with plasmids expressing either N‐terminal EGFP‐tagged wild‐type ZC4H2 or R67X mutant ZC4H2m. Anti‐GFP antibody was used to detect the N‐terminal EGFP‐tagged proteins by Western blot using 15%Tris‐Glycine SDS‐PAGE gel. β‐actin or β‐tubulin was used as control. (e) HEK293T cells were transiently transfected with plasmids expressing either empty vector, or C‐terminal Flag‐tagged wild‐type ZC4H2 and R67X mutant ZC4H2m. EGFP expression plasmid was co‐transfected for transfection efficiency control. Anti‐ZC4H2 antibody was used to detect the wildtype ZC4H2 protein. EGFP and β‐tubulin was used as control](MGG3-8-e1100-g003){#mgg31100-fig-0003}

3.3. Altered subcellular location of R67X mutant protein {#mgg31100-sec-0016}
--------------------------------------------------------

ZC4H2 protein contains a putative nuclear localization signal (NLS) within amino acids 207 to 224 (KAKSRSRNPKKPKRKQDE). Mutations in this area, such as R213W and K209N, were identified to interrupt nuclear transport (Hirata et al., [2013](#mgg31100-bib-0010){ref-type="ref"}; Kondo et al., [2018](#mgg31100-bib-0013){ref-type="ref"}). To investigate whether the newly identified nonsense mutation that abolished the nuclear localization signal would affect the subcellular localization of the protein, EGFP was fused to the N‐terminus of the wild type and mutant ZC4H2 protein. The wild type (Figure [4](#mgg31100-fig-0004){ref-type="fig"}e‐h) and mutant plasmids (Figure [4](#mgg31100-fig-0004){ref-type="fig"}i‐l) as well as EGFP control plasmid (Figure [4](#mgg31100-fig-0004){ref-type="fig"}a‐d) were transfected into HEK293T cells, and the EGFP signals in cytoplasmic compartment and nuclei were analyzed using confocal fluorescent microscope. The results showed that wild‐type ZC4H2 had perinuclear and nuclear punctate pattern of EGFP signals in the cells (Figure [4](#mgg31100-fig-0004){ref-type="fig"}e‐h, m), but the truncated protein had no such clear punctate pattern (Figure [4](#mgg31100-fig-0004){ref-type="fig"}i‐l, m), indicating the mutant protein\'s trafficking was altered.

![Confocal microscopic analysis. HEK293T cells were transfected with plasmids expressing either the wild‐type ZC4H2 (e‐h) or mutant ZC4H2 c.199 C\>T (p. R67X) protein (i‐l) with N‐terminally tagged EGFP. The empty EGFP vector was used as the negative control (a‐d). Phalloidin 555 and DAPI were used to stain the cytoskeleton and nucleus, respectively. Merged images of EGFP, DAPI, and phalloidin 555 are observed in d, h, and l. (m) An increased presence of wild‐type N‐EGFP‐ZC4H2 protein punctuate aggregated in the cytosol while the truncated protein is in the cytosol and nuclei at the same time, similar to EGFP protein only](MGG3-8-e1100-g004){#mgg31100-fig-0004}

3.4. XCI of *ZC4H2* gene in the patient {#mgg31100-sec-0017}
---------------------------------------

In 2013, in order to investigate whether *ZC4H2* gene is subjected to XCI, its expression in blood lymphocytes was measured. It has been found that different XCI patterns may lead to the various phenotypes of female patients who have the same mutation in *ZC4H2* gene (Hirata et al., [2013](#mgg31100-bib-0010){ref-type="ref"}). However, other studies showed controversial results (May et al., [2015](#mgg31100-bib-0015){ref-type="ref"}; Zanzottera et al., [2017](#mgg31100-bib-0023){ref-type="ref"}). In order to confirm whether different XCI pattern is the cause of the serious phenotype of the female patient, we also extracted the patient\'s peripheral blood and performed XCI analysis. The assessment of the XCI pattern showed a ratio of 22:78 (Figure [5](#mgg31100-fig-0005){ref-type="fig"}), this random inactivation pattern further confirmed the hypothesis May et al. and Zanzottera et al. concluded in their study (May et al., [2015](#mgg31100-bib-0015){ref-type="ref"}; Zanzottera et al., [2017](#mgg31100-bib-0023){ref-type="ref"}), in which they found there was no significant correlation between XCI patterns and disease phenotypes, suggesting that there are other reasons to participate and requires further research.

![X‐chromosome inactivation analysis of the patient with the R67X ZC4H2 mutation (proband). Amplification peaks of the smaller and larger CAG repeat alleles of the androgen receptor gene before (a) and after (b) digestion with the enzyme HhaI. The *Y*‐axis shows the amplification peak values corresponding to the number of PCR products of each allele. The amplification values of the smaller size allele (279 bp), undigested and digested, were 1,286 and 782, respectively. For the larger size allele (287 bp), undigested and digested amplification values were 605 and 2,884, respectively. The calculated X‐chromosome inactivation ratio was 22:78 according to the method described before](MGG3-8-e1100-g005){#mgg31100-fig-0005}

4. DISCUSSION {#mgg31100-sec-0018}
=============

In 1985, Wieacker‐Wolff firstly described a family with 6 males, who had club feet, progressive distal muscular atrophy, oculomotor apraxia, dysarthria, and IDD. The syndrome with muscular atrophy was considered to be neurogenic. The family also had 12 healthy males and 22 females, suggesting that the pedigree is consistent with X‐linked recessive inheritance. However, the etiology was not clear until Kloos et al mapped the genetic defect to Xp11.3 ± 11.3 in 1997 (Kloos, Jakubiczka, Wienker, Wolff, & Wieacker, [1997](#mgg31100-bib-0012){ref-type="ref"}). ZC4H2 mutations were identified as the cause of the disease (Hirata et al., [2013](#mgg31100-bib-0010){ref-type="ref"}). There have been 7 missense mutations identified in 9 families, 1 chromosomal inversion caused by breakpoint in Xq11.2, 1 frameshift mutation, 2 nonsense mutations, and 4 deletions in sporadic cases (Figure [1](#mgg31100-fig-0001){ref-type="fig"}).

AMC may be an endophenotype of more than 400 disorders, 50 of which are identified to be X‐linked. Wieacker‐Wolff Syndrome has been considered as a disorder with X‐linked recessive inheritance (Wieacker et al., [1985](#mgg31100-bib-0021){ref-type="ref"}). However, females with heterozygous *ZC4H2* mutations found in 4 of 5 families and 2 sporadic cases were developed the symptoms including equinovarus feet and mild ID. In this study, the author also found that women carrying the same mutations may have different phenotypes and suggested that nonrandom XCI might be responsible for this phenomenon (Hirata et al., [2013](#mgg31100-bib-0010){ref-type="ref"}). However, it was found that even in female patients with the same mutation and similar phenotypes, their XCI was varied (May et al., [2015](#mgg31100-bib-0015){ref-type="ref"}). A female patient with a severe phenotype caused by a small heterozygous deletion of the *ZC4H2* gene at Xq11.2 and a female with a mild phenotype caused by a p.Q50X nonsense mutation showed randomized X inactivation. These results indicate that there is no strong correlation between X inactivation and disease phenotype. The proband patient in our current study carrying a nonsense mutation (p.R67X) for a truncated protein with a more serious phenotype showed an XCI ratio of 22:78, which also suggests that X inactivation could not account for the phenotypic discrepancy in the ZC4H2 mutations‐associated WWS female patients. It is likely that the ZC4H2 deletion or nonsense mutations have a stronger detrimental effect on ZC4H2 function that leads to WWS in heterozygous female carriers while these mutations would be lethal to males. The data may suggest that a partial loss of ZC4H2 protein function may be enough to trigger the pathogenesis of WWS. This does not rule out the truncated protein could have abnormal gain of function to lead to WWS pathogenesis. Using the I‐TASSER program to analyze ZC4H2 protein\'s structure and function (Roy, Kucukural, & Zhang, [2010](#mgg31100-bib-0019){ref-type="ref"}; Wang, Virtanen, Xue, & Zhang, [2017](#mgg31100-bib-0020){ref-type="ref"}; Yang & Zhang, [2015](#mgg31100-bib-0022){ref-type="ref"}), all reported mutations were located in the first helix and last coiled‐coil region (Figure [6](#mgg31100-fig-0006){ref-type="fig"}), suggesting that the helix and coil domain may be essential for its function.

![Protein structure by I‐TASSER modeling. (a) The secondary structural of ZC4H2 protein, helix are shown in red, and the coil is in black. "＊" represents the previous reported pointed, nonsense and frameshift mutations, and the present mutation is shown in blue "＊". (b) The 3‐dimensional atomic model based on the protein sequence generated by the iterative threading assembly refinement server](MGG3-8-e1100-g006){#mgg31100-fig-0006}

In summary, we identified a novel nonsense mutation in *ZC4H2* gene in a female patient suffering from severe Wieacker‐Wolff syndrome and this mutation results in a truncated ZC4H2 protein. We have shown the mutation affects the protein\'s trafficking and XCI might not be responsible for its detrimental effect. The results suggest that female heterozygous carriers with loss of or a truncated ZC4H2 protein could also lead to the pathogenesis of Wieacker‐Wolff syndrome. Further study is warranted to define this mutation\'s effect on ZC4H2\'s function and its role in the pathogenesis of Wieacker‐Wolff syndrome.
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